P. Kent Hawryluk is President and Chief Executive Officer of MBX Biosciences, Inc. (MBX). The company reported total compensation of $2,990,867 for fiscal year 2025.
| Salary | $625,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $1,998,092 |
| Non-equity incentive plan | $359,375 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $8,400 |
| Total | $2,990,867 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure MBX Biosciences, Inc. filed April 22, 2026, accession 0001193125-26-168536.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| P. Kent Hawryluk this page | President and Chief Executive Officer | $2,990,867 |
| Richard Bartram | Former Chief Financial Officer | $1,496,275 |
| Salomon Azoulay | Chief Medical Officer | $1,474,978 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full MBX Biosciences, Inc. compensation brief.
P. Kent Hawryluk's compensation sits inside MBX Biosciences, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.